Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Kulagin AD, Ptushkin VV, Lukina EA, Davydkin IL, et al. Ann Hematol 2021;100:2689-2698.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kulagin AD, Ptushkin VV, Lukina EA, Davydkin IL, et al. Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Ann Hematol 2021;100:2689-2698.
PMID: 34398258